Perspective Therapeutics Inc (CATX)
EBITDA Margin
-31574.07%
Quarterly · Period ending:
CATX EBITDA Margin
Latest reported-31574.07%period ending
Latest reported-31574.07%period ending
CATX Quarterly EBITDA Margin (0.00% → -31574.07%)
Quarterly ebitda margin
High-resolution chart · PNG
CATX ebitda margin history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| -31,574.0741% | |
| -35,730.2632% | |
| 0% | |
| -12,023.445% | |
| -7,292.069% | |
| -4,851.4905% | |
| 0% | |
| 0% | |
| -3,825.5385% | |
| -3,403.6232% | |
| 163.8481% | |
| -518.1513% | |
| -1,614.1156% | |
| -601.4208% | |
| -161.0354% | |
| -241.1182% | |
| -81.477% | |
| -45.0859% | |
| -55.9304% | |
| -86.3885% | |
| -38.7823% | |
| -28% | |
| -34.4214% | |
| -28.5235% | |
| -50.6801% | |
| -17.7778% | |
| -39.1659% | |
| -34.4708% | |
| -59.4595% | |
| -60.5509% | |
| -77.4685% | |
| -95.1344% | |
| -147.0992% | |
| -83.8525% | |
| -95.5729% | |
| -126.6722% | |
| -135.3285% | |
| -106.9423% | |
| -141.0506% | |
| -146.716% | |
| -102.1323% | |
| 11.5125% | |
| 11.5222% | |
| 10.8616% | |
| -82.2495% | |
| -73.2213% | |
| -76.2752% | |
| -88.1336% | |
| -122.2355% | |
| -68.875% | |
| -81.6329% | |
| -100.7559% | |
| -68.0532% | |
| -51.8074% | |
| -94.0635% | |
| -98.9757% | |
| -40.2323% | |
| -58.3098% | |
| -60.1791% | |
| -72.9766% | |
| -22.7352% | |
| -21.9046% | |
| -90.944% | |
| -48.5223% | |
| -59.9453% | |
| -71.1373% | |
| -51.3938% | |
| -47.3001% | |
| -78.4276% | |
| -86.484% | |
| -166.9656% | |
| -78.6826% | |
| -57.9561% | |
| -95.1158% | |
| -147.3435% | |
| -116.3925% | |
| -152.227% | |
| -115.8999% | |
| -125.5979% | |
| -271.6055% | |
| -307.6026% | |
| -225.1151% | |
| -247.0592% | |
| -810.5009% | |
| 48.1488% | |
| 92.3077% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |